Paper
H(1) antihistamine drug promethazine directly blocks hERG K(+) channel.
Published Nov 1, 2009 · S. Jo, Hee-Kyung Hong, Seon-Ha Chong
Pharmacological research
39
Citations
0
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
In Vitro Study
Study Snapshot
Promethazine is a blocker of hERG channels, providing a molecular mechanism for its arrhythmogenic side effects during clinical administration.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Full text analysis coming soon...
References
—
···
—
···
—
···
—
···
—
···
—
···
—
···
—
···
Citations
—
···
—
···
—
···
—
···
—
···
—
···
—
···
—
···